Ozempic (semaglutide) is a prescription drug used for certain conditions in people with type 2 diabetes. Ozempic is given as an injection under your skin. Ozempic can be prescribed for adults with ...

Semaglutide is an injectable medication typically used to treat diabetes. However, it can also be prescribed for weight loss under the brand name Wegovy. Semaglutide is a prescription medication ...

A once-weekly injection of semaglutide could cut alcohol cravings and reduce the amount someone living with alcohol use disorder (AUD) drinks on some days in a given week, according to results ...

Also, in a 40-week trial comparing tirzepatide to semaglutide in individuals with type 2 diabetes, those on tirzepatide lost more weight. But the study also found that five to seven percent of ...

The FDA has determined that the nationwide shortage of semaglutide injection, used for both diabetes and weight loss, is resolved after more than two years of limited availability due to high demand.

The Food and Drug Administration said on Friday that the shortage of semaglutide injection products, such as Novo Nordisk's Wegovy, has been resolved. FDA's update led to renewed uncertainty for a ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Semaglutide and tirzepatide treatment lead to ... and then for up to one year for each participant. Mean age (40 vs. 41 years), sex (71 vs. 72 % female), diabetes duration (26 vs.

Semaglutide could help people drink less alcohol ... at Lankenau Medical Center and a member of the ABC News Medical Unit.

Researchers found that among semaglutide users, the incidence rate of nonarteritic anterior ischemic optic neuropathy was 14.5 per 100,000 person-years. HealthDay News — For individuals with ...